Bluejay Diagnostics (BJDX) Total Non-Current Liabilities (2020 - 2026)

Bluejay Diagnostics (BJDX) has 6 years of Total Non-Current Liabilities data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 0.7% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 0.7% YoY), and the FY2025 full-year result was $1.1 million, up 23.94% from the prior year.
• Total Non-Current Liabilities rose to $1.4 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $919357.0 in Q4 2024.
• A 5-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities surged 60.72% in 2023 and sank 60.95% in 2024, its largest moves.
• Tracing BJDX's Total Non-Current Liabilities over 5 years: stood at $2.0 million in 2022, then fell by 0.14% to $2.0 million in 2023, then plunged by 53.13% to $919357.0 in 2024, then increased by 23.94% to $1.1 million in 2025, then advanced by 24.09% to $1.4 million in 2026.
• Business Quant data shows BJDX's Total Non-Current Liabilities at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.